StonvexLoading…
StonvexStonvexStonvexCore line items from PFHO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.72M | $6.07M | $5.63M | $5.74M |
Operating Income | $1.00M | $852.62K | $678.53K | $666.12K |
Net Income | $1.39M | $883.58K | $767.93K | $492.89K |
EPS (Diluted) | $0.11 | $0.07 | $0.06 | $0.04 |
Total Assets | $13.46M | $12.43M | $11.75M | $12.05M |
Total Liabilities | Not available | $745.60K | $948.26K | $735.07K |
Cash & Equivalents | $2.17M | $2.07M | $2.49M | $2.04M |
Free Cash Flow OCF − CapEx | $1.14M | $665.95K | $914.84K | $672.37K |
Shares Outstanding | 12.80M | 12.80M | 12.80M | 12.80M |